AQR Capital reports 2.45% DENTSPLY SIRONA (XRAY) ownership in Schedule 13G/A

Rhea-AI Filing Summary

AQR Capital Management Holdings, LLC and its wholly owned subsidiary AQR Capital Management, LLC report beneficial ownership of DENTSPLY SIRONA Inc. common stock. They disclose beneficially owning 4,898,136 shares, representing 2.45% of the outstanding common stock.

The firms report shared voting and dispositive power over all of these shares and no sole voting or dispositive power. They certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of DENTSPLY SIRONA.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

DENTSPLY SIRONA Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

24906P109

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 24906P109

1

Names of Reporting Persons

AQR Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,898,136.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,898,136.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,898,136.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.45 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 24906P109

1

Names of Reporting Persons

AQR Capital Management Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,898,136.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,898,136.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,898,136.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.45 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: DENTSPLY SIRONA Inc.
(b)	Address of issuer's principal executive offices: 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NORTH CAROLINA 28277-3607
Item 2.
(a)	Name of person filing: AQR Capital Management, LLC AQR Capital Management Holdings, LLC
(b)	Address or principal business office or, if none, residence: ONE GREENWICH PLAZA SUITE 130 Greenwich, Connecticut 06830
(c)	Citizenship: AQR Capital Management, LLC - UNITED STATES AQR Capital Management Holdings, LLC - UNITED STATES
(d)	Title of class of securities: Common stock, par value $0.01 per share
(e)	CUSIP No.: 24906P109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,898,136
(b)	Percent of class: 2.45 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0
	(ii) Shared power to vote or to direct the vote: AQR Capital Management, LLC - 4,898,136 AQR Capital Management Holdings, LLC - 4,898,136
	(iii) Sole power to dispose or to direct the disposition of: AQR Capital Management, LLC - 0 AQR Capital Management Holdings, LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: AQR Capital Management, LLC - 4,898,136 AQR Capital Management Holdings, LLC - 4,898,136
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Item 2(a) above.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AQR Capital Management, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	02/12/2026

AQR Capital Management Holdings, LLC

Signature:	Henry Parkin
Name/Title:	Authorized Signatory
Date:	02/12/2026

Exhibit Information

AQR Capital Management Holdings, LLC and AQR Capital Management, LLC hereby agree that this Schedule 13G is filed on behalf of each of the parties. AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.

FAQ

What stake in DENTSPLY SIRONA (XRAY) does AQR report in this Schedule 13G/A?

AQR reports beneficial ownership of 4,898,136 shares of DENTSPLY SIRONA common stock, representing 2.45% of the company’s outstanding shares. This stake is disclosed as being held with shared voting and dispositive power by the AQR reporting entities.

Which AQR entities are reporting ownership of DENTSPLY SIRONA (XRAY)?

The reporting entities are AQR Capital Management Holdings, LLC and AQR Capital Management, LLC. The filing states that AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC, and both report the same beneficial ownership position.

How much voting power does AQR have over its DENTSPLY SIRONA (XRAY) shares?

AQR reports 0 shares with sole voting power and 4,898,136 shares with shared voting power. The same numbers apply to dispositive power, indicating all reported shares are controlled jointly rather than solely by a single reporting entity.

Is AQR’s ownership of DENTSPLY SIRONA (XRAY) above or below 5% of the class?

AQR’s beneficial ownership is reported at 2.45% of DENTSPLY SIRONA’s common stock, which is below 5% of the class. The filing explicitly notes ownership of 5 percent or less of the class in the relevant ownership item.

What does AQR say about its intent regarding control of DENTSPLY SIRONA (XRAY)?

AQR certifies the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing control of DENTSPLY SIRONA, nor in connection with any transaction having that control-related purpose or effect.

Where are the principal offices of DENTSPLY SIRONA and AQR located?

DENTSPLY SIRONA’s principal executive offices are at 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607. AQR’s principal business office is at One Greenwich Plaza, Suite 130, Greenwich, Connecticut 06830, as disclosed in the ownership statement.